Sofinnova Investments, Inc.
CIK:0001631134
Venture Capital
$4B AUM
63 holdings
Menlo Park, CA, USA
Sofinnova Investments is a venture capital firm focused on early-stage life science and IT companies.
Investment Strategy
Early-stage life science and IT investments
Top Buys
G
GILDGilead Sciences Inc+$69.5M
A
ABBVAbbVie Inc+$49.3M
B
BSXBoston Scientific Corp+$46.3M
N
NTRANatera Inc+$42.7M
U
UTHRUnited Therapeutics Corp+$34.1M
Top Sells
S
SYKStryker Corporation-$111.1M
M
MDTMedtronic PLC-$50.6M
A
ALNYAlnylam Pharmaceuticals Inc-$47.6M
B
BPMCBlueprint Medicines Corp-$23.1M
B
BMYBristol-Myers Squibb Co-$22.7M
Top Holdings
N
NTRANatera Inc+16.0%$261.9M
G
GILDGilead Sciences Inc+7.1%$116.4M
L
LLYEli Lilly and Co+4.6%$75.6M
J
JAZZJazz Pharmaceuticals PLC+4.5%$73.7M
V
VERAVera Therapeutics Inc+4.0%$65.8M
Equity Positions (55)
| Ticker | Security | Weight | Market Value | Shares | Avg Cost | Price | Change (QoQ) |
|---|---|---|---|---|---|---|---|
N NTRA | Natera Inc | 16.02% | $261.9M | 1,550,280 | $9.35 | $168.94 | +$42.7M |
G GILD | Gilead Sciences Inc | 7.12% | $116.4M | 1,050,308 | $103.49 | $110.87 | +$69.5M |
L LLY | Eli Lilly and Co | 4.63% | $75.6M | 97,018 | $796.79 | $779.53 | +$32.0M |
J JAZZ | Jazz Pharmaceuticals PLC | 4.50% | $73.7M | 694,096 | $115.45 | $106.12 | +$10.3M |
V VERA | Vera Therapeutics Inc | 4.03% | $65.8M | 2,793,987 | $13.59 | $23.56 | -$1.3M |
Options Positions (8)
| Ticker | Security | Action | Type | Notional Value | Contracts | Underlying Price | Premium Paid | Change (Contracts) | Change (Value) |
|---|---|---|---|---|---|---|---|---|---|
I IWM | iShares TR | Sold | Put | $53.9M | 2,500 | $215.79 | $199.49 | -1,000 | -$15.9M |
I IBB | iShares TR | New | Put | $47.4M | 3,750 | $126.51 | $126.51 | +3,750 | +$47.4M |
S SMMT | Summit Therapeutics Inc | New | Call | $14.9M | 7,000 | $21.28 | $21.28 | +7,000 | +$14.9M |
R RYTM | Rhythm Pharmaceuticals Inc | New | Put | $14.2M | 2,250 | $63.19 | $63.19 | +2,250 | +$14.2M |
R REPL | Replimune Group Inc | New | Put | $13.9M | 15,000 | $9.29 | $9.29 | +15,000 | +$13.9M |
Industry Allocation
PHARMACEUTICAL PREPARATIONS
+55.2%
SERVICES-MEDICAL LABORATORIES
+16.7%
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
+12.3%
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
+5.6%
ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
+2.4%